معرفی
Dr. Aamna AlShehhi serves as an Assistant Professor in the Department of Biomedical Engineering and Biotechnology at Khalifa University, where she has pioneered AI-driven healthcare solutions since joining in 2020. Her interdisciplinary expertise bridges electrical engineering, computer science, and clinical medicine through innovative research collaborations with MIT, Imperial College London, and Novartis.
Her educational foundation includes:
- Bachelor's in Software Engineering, United Arab Emirates University (2009)
- Master's in Computing and Information Science, Masdar Institute (MIT collaboration) (2013)
- PhD in Interdisciplinary Engineering, Masdar Institute (MIT collaboration) (2017)
Dr. AlShehhi's research centers on artificial intelligence for healthcare transformation, with emphasis on neurodegenerative disease prediction, rare disease diagnostics, and wearable-based gait analysis. She develops constrained deep learning models for Alzheimer's biomarker discovery, self-supervised frameworks for emotion recognition using smartphone data, and physics-informed neural networks for biomechanical analysis. Her work integrates multimodal data including fMRI, genomic sequences, and real-world behavioral metrics to address critical gaps in dementia screening, cancer detection, and mental health monitoring.
Analysis of her 2023-2025 publications reveals three dominant trends: (1) Explainable AI architectures for clinical decision support, particularly constrained graph neural networks analyzing comorbidity networks in Alzheimer's; (2) Multimodal sensor fusion systems combining wearables, keystroke dynamics, and fMRI for neurological assessment; (3) Self-supervised learning approaches enabling robust performance with limited medical data. Her work consistently targets real-world clinical deployment through portable systems like smart gait analyzers and remote depression screening tools.
Dr. AlShehhi actively mentors the next generation of biomedical engineers:
- Ferial J. Abuhantash (Ph.D. candidate)
- Khalid Ahmed Abdulla (Master's student)
Her research is supported through strategic partnerships with Novartis Institute for Biomedical Research and collaborative grants enabling AI-driven drug repurposing for dementia and genomic cancer detection. She leads projects analyzing skin lesions for melanoma screening and developing deep learning models for early-stage cancer detection using genomic data.
As a core member of Khalifa University's Healthcare Engineering Innovation Group, she directs a multidisciplinary team including Postdoctoral Fellow Dr. Sherlyn Jemimah and Research Assistant Chahd Maher Musthafa Chabib. Current initiatives focus on creating deployable AI systems for clinical settings, with ongoing work on portable gait assessment tools for rehabilitation centers and real-time emotion recognition platforms for mental health monitoring.
.jpg)
